Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06XSG
|
|||
Former ID |
DCL000482
|
|||
Drug Name |
AZD8075
|
|||
Indication | Chronic obstructive pulmonary disease [ICD-11: CA22; ICD-10: J44, J44.9] | Discontinued in Phase 1 | [1] | |
Company |
AstraZeneca
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Prostaglandin D2 receptor 2 (PTGDR2) | Target Info | Antagonist | [2] |
Reactome | Prostanoid ligand receptors | |||
G alpha (i) signalling events | ||||
WikiPathways | GPCRs, Class A Rhodopsin-like | |||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800029210) | |||
REF 2 | Clinical pipeline report, company report or official report of AstraZeneca (2009). |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.